Current Month 2013
Article Features
  ALK1 Protein May Play a Role in Breast Cancer Metastasis
Anastrozole Prevents Recurrence More Than Tamoxifen in Some Patients with Noninvasive Breast Cancer
Benefit of Surgery for Ductal Carcinoma In-Situ Investigated
Breast Cancer Screening Reduces Risk of Death by 40 Percent
Breast Cancer Study Raises Hope of Therapy to Stop Tumor Spread
Breast-Conserving Therapy for Early-Stage Cancers Has Increased, Though Access An Issue
Cardio-Oncology Services May Improve Patient Care if More Widely Available
Daily Aspirin Could Block Growth of Breast, Other Cancers
“Death-Associated Protein” Promotes Cancer Growth in Aggressive Breast Cancers
Higher sTNF-RII Associated with Reduced Memory Functioning Among Breast Cancer Patients Before Treatment
Immune Signaling Protein Has Opposing Roles in Breast Cancer Development
Massively Parallel Gene Function Assays Aim to Reduce Uncertainty of Genetic Diagnoses
Mini-Breast Grown in Petri Dishes – A New Tool for Cancer Research
Most Women with Early-Stage Breast Cancer Undergo Imaging for Metastatic Cancer Despite Guidelines
Panel Recommends Improvements in Estrogen Testing Accuracy
Practice-Changing Study Offers New Option for Tough Breast Cancer Cases
Prenatal DDT Exposure Tied to Nearly 4-Fold Increase in Breast Cancer Risk
Sleep Duration and Quality May Impact Cancer Survival Rate
Smoking May Impact Survival After a Breast Cancer Diagnosis
Stress Hormones Could Undermine Breast Cancer Therapy
Study Finds Gene Mutations Sensitize Tumors to Specific Cancer Drugs
Study Finds Misperceptions About Impact of Double Mastectomy


Study Finds Misperceptions About Impact of Double Mastectomy

A survey of women with breast cancer found that nearly half considered having a double mastectomy. But of those who considered it, only 37 percent knew that the more aggressive procedure does not improve survival for women with breast cancer.

Among women who received a double mastectomy, 36 percent believed it would improve their survival. Studies have shown that for women at average risk of a second cancer, removing the unaffected breast does not meaningfully improve survival.

The study, which was presented at the American Society of Clinical Oncology annual meeting in Chicago, looked at 1,949 women who had been treated for breast cancer. About 20 percent of the women surveyed had both breasts removed, a procedure called contralateral prophylactic mastectomy. Even among patients without a genetic mutation or family history that might put them at risk of developing cancer in the other breast, 19 percent had double mastectomy.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon